{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:42:56Z","timestamp":1792622576047,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.toxlet.2026.113209","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:52:18Z","timestamp":1792079538000},"page":"113209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The penetration of the Novichok nerve agent A-234 in a human skin model and the assessment of several decontamination procedures"],"prefix":"10.1016","volume":"426","author":[{"given":"Gabriele","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-5388","authenticated-orcid":false,"given":"Timo","family":"Wille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Steinritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0586-8660","authenticated-orcid":false,"given":"Niko","family":"Amend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.toxlet.2026.113209_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/nyas.14336","article-title":"Diagnostics and treatment of nerve agent poisoning-current status and future developments","volume":"1479","author":"Amend","year":"2020","journal-title":"Ann. New. Y. Acad. Sci."},{"issue":"1-2","key":"10.1016\/j.toxlet.2026.113209_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2006.04.030","article-title":"Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase","volume":"224","author":"Aurbek","year":"2006","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.toxlet.2026.113209_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0960327108090269","article-title":"Comparison of selected skin decontaminant products and regimens against VX in domestic swine","volume":"27","author":"Bjarnason","year":"2008","journal-title":"Human. & Exp. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113209_bib4","first-page":"1","article-title":"Development, Historical Use and Properties of Chemical Warfare Agents","volume":"1","author":"Black","year":"2016"},{"issue":"10","key":"10.1016\/j.toxlet.2026.113209_bib5","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00204-023-03574-5","article-title":"Catch-up\u201d therapy: combining antidotal treatment with dermal application of AHA following percutaneous VX poisoning in the domestic swine","volume":"97","author":"Bloch-Shilderman","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"5-6","key":"10.1016\/j.toxlet.2026.113209_bib6","doi-asserted-by":"crossref","first-page":"e1381","DOI":"10.1093\/milmed\/usad464","article-title":"Current Perspectives on the Management of Patients Poisoned With Novichok: A Scoping Review","volume":"189","author":"Blom","year":"2024","journal-title":"Mil. Med."},{"issue":"5","key":"10.1016\/j.toxlet.2026.113209_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00204-022-03273-7","article-title":"Recent research on Novichok","volume":"96","author":"Bolt","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2026.113209_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/15569527.2010.515280","article-title":"Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX","volume":"30","author":"Braue","year":"2011","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"8-9","key":"10.1016\/j.toxlet.2026.113209_bib9","article-title":"After Salisbury Nerve Agents Revisited","volume":"38","author":"Carlsen","year":"2019","journal-title":"Mol. Inform."},{"key":"10.1016\/j.toxlet.2026.113209_bib10","unstructured":"CDC, 2026. About Getting Clean, https:\/\/www.cdc.gov\/chemical-emergencies\/response\/get-clean.html?utm_source=chatgpt.com#print."},{"issue":"1","key":"10.1016\/j.toxlet.2026.113209_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/24734306.2018.1475151","article-title":"Novichok agents: a historical, current, and toxicological perspective","volume":"2","author":"Chai","year":"2018","journal-title":"Toxicol. Commun."},{"issue":"10","key":"10.1016\/j.toxlet.2026.113209_bib12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1177\/0748233712448112","article-title":"Skin decontamination: principles and perspectives","volume":"29","author":"Chan","year":"2013","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.toxlet.2026.113209_bib13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/B978-0-12-819090-6.00073-8","article-title":"Rapid decontamination of chemical warfare agents from skin","author":"Clarkson","year":"2020","journal-title":"Handb. Toxicol. Chem. warefare Agents Acad. Press. Lond. U. Kingd."},{"key":"10.1016\/j.toxlet.2026.113209_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111001","article-title":"Effective skin decontamination with RSDL\u00ae (reactive skin decontamination lotion kit) following dermal exposure to a Novichok class nerve agent","volume":"395","author":"Cornelissen","year":"2024","journal-title":"Chem. -Biol. Interact."},{"issue":"1","key":"10.1016\/j.toxlet.2026.113209_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1432-1033.1984.tb08079.x","article-title":"Kinetics for the inhibition of acetylcholinesterase from the electric eel by some organophosphates and carbamates","volume":"140","author":"Forsberg","year":"1984","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxlet.2026.113209_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxlet.2024.02.014","article-title":"Reactive skin decontamination lotion (RSDL) safety with clinical antiseptics and hemostatic agents","volume":"395","author":"Franken","year":"2024","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.toxlet.2026.113209_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archinte.1956.00250260095010","article-title":"The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds","volume":"98","author":"Grob","year":"1956","journal-title":"A. M. A. Arch. Intern. Med."},{"issue":"15","key":"10.1016\/j.toxlet.2026.113209_bib18","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/bi00739a026","article-title":"Recording spectrophotometric method for determination of dissociation and phosphorylation constants for the inhibition of acetylcholinesterase by organophosphates in the presence of substrate","volume":"12","author":"Hart","year":"1973","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.toxlet.2026.113209_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e03153","article-title":"Hydrolysis and enzymatic degradation of Novichok nerve agents","volume":"6","author":"Harvey","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.toxlet.2026.113209_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.toxlet.2024.04.003","article-title":"Inhibition kinetics of acetylcholinesterase and butyrylcholinesterase from various species by 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP)","volume":"396","author":"Horn","year":"2024","journal-title":"Toxicol. Lett."},{"issue":"8","key":"10.1016\/j.toxlet.2026.113209_bib21","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1007\/s00204-025-04059-3","article-title":"Concentration-time profiles of the nerve agent VX and the pesticide parathion in five different cell culture plates","volume":"99","author":"Horn","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113209_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2026.111911","article-title":"A full thickness in vitro model of human skin for the penetration of highly toxic VX and the evaluation of different decontaminants","volume":"421","author":"Horn","year":"2026","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.toxlet.2026.113209_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00204-024-03689-3","article-title":"A-series agent A-234: initial in vitro and in vivo characterization","volume":"98","author":"Hrabinova","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.toxlet.2026.113209_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bja.2019.04.061","article-title":"Organophosphorus nerve agent poisoning: managing the poisoned patient","volume":"123","author":"Hulse","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.toxlet.2026.113209_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbi.2016.02.001","article-title":"The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure","volume":"267","author":"Joosen","year":"2017","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.toxlet.2026.113209_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.131150","article-title":"Elimination of A-234 from the environment: Effect of different decontaminants","volume":"451","author":"Jung","year":"2023","journal-title":"J. Hazard. Mater."},{"issue":"7","key":"10.1016\/j.toxlet.2026.113209_bib27","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00204-023-03521-4","article-title":"Evidence of nerve agent VX exposure in rat plasma by detection of albumin-adducts in vitro and in vivo","volume":"97","author":"Kranawetvogl","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"1A","key":"10.1016\/j.toxlet.2026.113209_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/026119290403201s12","article-title":"Full Thickness EpiDerm: a dermal-epidermal skin model to study epithelial-mesenchymal interactions","volume":"32","author":"Kubilus","year":"2004","journal-title":"Altern. Lab. Anim. ATLA"},{"issue":"1","key":"10.1016\/j.toxlet.2026.113209_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0163-7258(93)90066-M","article-title":"Organophosphate poisoning","volume":"58","author":"Marrs","year":"1993","journal-title":"Pharmacol. & Ther."},{"key":"10.1016\/j.toxlet.2026.113209_bib30","series-title":"State secrets: an insider\u2019s chronicle of the Russian Chemical Weapons Program","author":"Mirzayanov","year":"2008"},{"issue":"12","key":"10.1016\/j.toxlet.2026.113209_bib31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1289\/ehp.99107933","article-title":"The sources, fate, and toxicity of chemical warfare agent degradation products","volume":"107","author":"Munro","year":"1999","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.toxlet.2026.113209_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120689","article-title":"Towards catch-up therapy: evaluation of nucleophilic active pharmaceutical ingredients for the treatment of percutaneous VX poisoning, in-vial and in-vitro studies","volume":"603","author":"Nahum","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.toxlet.2026.113209_bib33","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00204-026-04355-6","article-title":"AHAK: a new effective medical countermeasure against percutaneous intoxication by Novichok chemical warfare agents","volume":"100","author":"Nili","year":"2026","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113209_bib34","unstructured":"OPCW, 2020. Case of Mr Alexei Navalny. https:\/\/www.opcw.org\/ https:\/\/www.opcw.org\/media-centre\/featured-topics\/case-mr-alexei-navalny. Accessed 29 June 2026."},{"issue":"10","key":"10.1016\/j.toxlet.2026.113209_bib35","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s00204-023-03571-8","article-title":"A-agents, misleadingly known as \u201cNovichoks\u201d: a narrative review","volume":"97","author":"Opravil","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113209_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cplett.2021.139116","article-title":"Theoretical evaluation of the hydrolysis of conventional nerve agents and novichok agents","volume":"785","author":"Otsuka","year":"2021","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.toxlet.2026.113209_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxlet.2025.01.002","article-title":"A simple acetylcholinesterase inhibition assay for the quantification of the nerve agent VX: Application in a Franz cell model with rat skin and various decontaminants","volume":"404","author":"Schwab","year":"2025","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2026.113209_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2026.112028","article-title":"A three-dimensional, bioartificial human skin equivalent as an innovative technology for studying the decontamination of the nerve agent VX","author":"Schwab","year":"2026","journal-title":"Chem. -Biol. Interact."},{"issue":"10","key":"10.1016\/j.toxlet.2026.113209_bib39","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/138920112802273191","article-title":"Reactive skin decontamination lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure","volume":"13","author":"Schwartz","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"10270","key":"10.1016\/j.toxlet.2026.113209_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(20)32644-1","article-title":"Novichok nerve agent poisoning","volume":"397","author":"Steindl","year":"2021","journal-title":"Lancet (Lond. Engl. )"},{"key":"10.1016\/j.toxlet.2026.113209_bib41","first-page":"1","article-title":"Treatment of Nerve Agent Poisoning","volume":"2","author":"Thiermann","year":"2016"},{"issue":"6","key":"10.1016\/j.toxlet.2026.113209_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/15563650.2025.2501266","article-title":"Approaches to the treatment of nerve agent poisoning with oximes - from experimental studies to the intensive care unit","volume":"63","author":"Thiermann","year":"2025","journal-title":"Clinical toxicology (Philadelphia Pa. )"},{"key":"10.1016\/j.toxlet.2026.113209_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tiv.2016.01.003","article-title":"vitro human skin penetration model for organophosphorus compounds with different physicochemical properties","volume":"32","author":"Thors","year":"2016","journal-title":"Toxicology vitro international journal published association BIBRA"},{"key":"10.1016\/j.toxlet.2026.113209_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cbi.2017.06.002","article-title":"Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin","volume":"273","author":"Thors","year":"2017","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.toxlet.2026.113209_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.toxlet.2017.02.001","article-title":"RSDL decontamination of human skin contaminated with the nerve agent VX","volume":"269","author":"Thors","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.toxlet.2026.113209_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/15569527.2021.1902342","article-title":"Efficient agent degradation within skin is important for decontamination of percutaneously exposed VX","volume":"40","author":"Thors","year":"2021","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113209_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109135","article-title":"Improved skin decontamination efficacy for the nerve agent VX","volume":"325","author":"Thors","year":"2020","journal-title":"Chem. -Biol. Interact."},{"issue":"1","key":"10.1016\/j.toxlet.2026.113209_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00204-025-04216-8","article-title":"Challenges and advances in the development of antidotes against A-series nerve agents","volume":"100","author":"Tripathy","year":"2026","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113209_bib49","unstructured":"U.S. Army Medical Research Institute of Chemical Defense, 2014. Medical management of chemical causalties handbook, Chemical Causualty Care Division, Aberdeen Proving Ground, Maryland."},{"issue":"1","key":"10.1016\/j.toxlet.2026.113209_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.55460\/COFJ-WMPA","article-title":"Decontamination of Toxic Industrial Chemicals and Fentanyl by Application of the RSDL\u00ae Kit","volume":"20","author":"Verheij","year":"2020","journal-title":"J. Spec. Oper. Med. a peer Rev. J. SOF Med. Prof."},{"issue":"1-2","key":"10.1016\/j.toxlet.2026.113209_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0009-8981(99)00144-8","article-title":"Improved determination of acetylcholinesterase activity in human whole blood","volume":"288","author":"Worek","year":"1999","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"2","key":"10.1016\/j.toxlet.2026.113209_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pharmthera.2013.04.009","article-title":"The value of novel oximes for treatment of poisoning by organophosphorus compounds","volume":"139","author":"Worek","year":"2013","journal-title":"Pharmacol. & Ther."},{"issue":"11","key":"10.1016\/j.toxlet.2026.113209_bib53","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bcp.2004.07.038","article-title":"Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes","volume":"68","author":"Worek","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2026.113209_bib54","first-page":"157","article-title":"Clinical and Laboratory Diagnosis of Chemical Warfare Agent Exposure","volume":"2","author":"Worek","year":"2016"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427426024380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427426024380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:33:20Z","timestamp":1792622000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427426024380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":54,"alternative-id":["S0378427426024380"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2026.113209","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The penetration of the Novichok nerve agent A-234 in a human skin model and the assessment of several decontamination procedures","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2026.113209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113209"}}